Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.9% sodium chloride----5件: 6, 14, 51, 53, 65 💬
216,5% cutaquig----1件: 65 💬
32(S)-(acetylamino)-4-methylpentanoic acid----2件: 19, 65 💬
4A10bk03----1件: 65 💬
5Abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
6Acetamide1件: Acetamide---1件: 65 💬
7Adagen----1件: 65 💬
8Adenosine1件: Adenosine1件: Adenosine 💬 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		13件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 13, 58, 65 💬
9Administration OF drug (interferon-gamma 1-B) subcutaneously----1件: 65 💬
10Adverse reactions OF gammagard subcutaneously AT week 12----1件: 65 💬
11Adverse reactions OF gammagard subcutaneously AT week 24----1件: 65 💬
12Adverse reactions OF gammagard subcutaneously AT week 36----1件: 65 💬
13Adverse reactions OF gammagard subdermally AT week 12----1件: 65 💬
14Adverse reactions OF gammagard subdermally AT week 24----1件: 65 💬
15Adverse reactions OF gammagard subdermally AT week 36----1件: 65 💬
16ADX-324----1件: 65 💬
17Aldesleukin1件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬5件: 2, 49, 65, 96, 97 💬
18Alefacept1件: Alefacept1件: Alefacept 💬 1件: CD58 💬 2件: Cell adhesion molecules, Epstein-Barr virus infection 💬6件: 37, 60, 65, 164, 284, 285 💬
19Alemtuzumab1件: Alemtuzumab1件: Alemtuzumab 💬 --18件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬
20Alemtuzumab 0.2 MG1件: Alemtuzumab1件: Alemtuzumab 💬 --2件: 65, 164 💬
21Alemtuzumab 0.3 MG1件: Alemtuzumab1件: Alemtuzumab 💬 --2件: 65, 164 💬
22Allo BMT----1件: 65 💬
23Allogeneic bone marrow transplantation----8件: 60, 62, 65, 96, 164, 284, 285, 286 💬
24Allogeneic hematopoietic stem cell transplantation----8件: 28, 51, 60, 62, 65, 164, 284, 285 💬
25Allogeneic HSC----1件: 65 💬
26Allogeneic hsct----1件: 65 💬
27Allogeneic peripheral blood stem cell----1件: 65 💬
28ANTI-CD45----2件: 65, 285 💬
29ANTI-thymocyte globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
30Antithymocyte globulin----3件: 60, 65, 284 💬
31AP1903----4件: 60, 65, 285, 326 💬
32ARA-C----1件: 65 💬
33Argininhydrochlorid----1件: 65 💬
34Autologous CD34 positive cells transduced with A lentiviral vector containing human WAS gene----1件: 65 💬
35Autologous CD34+ cells transduced EX-vivo with THE pcclchimgp91/vsvg lentiviral vector----1件: 65 💬
36Autologous CD34+ cells transduced with THE G1xcgd lentiviral vector----1件: 65 💬
37Autologous CD34+ cells transduced with THE lentiviral vector containing THE human wiskott aldrich SY----1件: 65 💬
38Autologous CD34+ cells transduced with wasp lentiviral vector----1件: 65 💬
39Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes FOR THE human wiskott aldrich syndrome (WAS) cdna sequence----1件: 65 💬
40Autologous CD34+ hscs transduced EX vivo with EFS lentiviral vector encoding FOR THE human ADA gene----1件: 65 💬
41Autologous CD34+cells transduced with THE W1.6_hwasp_wpre (vsvg) lentiviral vector----1件: 65 💬
42Avoralstat1件: Avoralstat---1件: 65 💬
43AVTX-803----1件: 65 💬
44Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--22件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
45Baclofen1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬7件: 2, 10, 13, 18, 65, 149, 206 💬
46Bacteriophage----1件: 65 💬
47BASE-edited hematopoietic stem and progenitor cells----1件: 65 💬
48BC7353----1件: 65 💬
49BCX41611件: Avoralstat---1件: 65 💬
50BCX73531件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
51BCX7353 + digoxin1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
52BCX7353 and probes1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
53BCX7353 capsules1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
54Berinert----1件: 65 💬
55Berinert P----1件: 65 💬
56Berinert*IV FL 500U+FL 10ML----1件: 65 💬
57Berinert, lyophilizate FOR IV application containing 500 IU C1-INH TO BE reconstituted with 10 ML water FOR injection1件: Human C1-esterase inhibitor---1件: 65 💬
58Berinert® P----1件: 65 💬
59Berinert®, 20 ??/ KG----1件: 65 💬
60Berotralstat1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
61Betamethasone oral solution period 1 and period 21件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
62Betamethasone solution AS intramuscular injection period 1 and period 21件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
63Biological NTLA-2002----1件: 65 💬
64Biological sampling----2件: 65, 97 💬
65Biopsy----6件: 28, 34, 51, 65, 193, 285 💬
66Biopsy procedure----1件: 65 💬
67Biospecimen collection----18件: 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
68Bivigam----1件: 65 💬
69Blood draw----7件: 6, 19, 65, 67, 96, 231, 299 💬
70Blood drawing IN healthy controls----1件: 65 💬
71Blood drawing IN patients with WAS----1件: 65 💬
72Blood sample----28件: 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
73BMS-188667----10件: 46, 49, 53, 65, 96, 97, 107, 160, 222, 271 💬
74Bone marrow aspiration----8件: 2, 28, 60, 62, 65, 284, 285, 286 💬
75Bone marrow biopsy----7件: 26, 28, 60, 62, 65, 284, 286 💬
76Boya ivig----1件: 65 💬
77BPX-501 T cells----4件: 65, 284, 285, 326 💬
78BT090----1件: 65 💬
79BT524----1件: 65 💬
80BT595----2件: 63, 65 💬
81BT681----1件: 65 💬
82Busilvex1件: Busulfan1件: Busulfan 💬 --4件: 19, 36, 60, 65 💬
83Busilvex - 6 MG/ML - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino - 10 ML 8 flaconcini1件: Busulfan1件: Busulfan 💬 --2件: 19, 65 💬
84Busulfan1件: Busulfan1件: Busulfan 💬 --14件: 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
85Busulfan test dose1件: Busulfan1件: Busulfan 💬 --1件: 65 💬
86Busulfan, cyclophosphamide, ATG, gcsf1件: Busulfan1件: Busulfan 💬 --2件: 65, 284 💬
87Busulfan, fludarabine, ATG, TLI1件: Busulfan1件: Busulfan 💬 --2件: 65, 284 💬
88BW-20805----1件: 65 💬
89C-1-esterase----1件: 65 💬
90C01eb19----1件: 65 💬
91C1 esterase inhibitor----1件: 65 💬
92C1 esterase inhibitor [human] liquid----1件: 65 💬
93C1 esterase inhibitor concentrate----1件: 65 💬
94C1 esterase inhibitor concentrate, human, pasteurized----1件: 65 💬
95C1 esterase inhibitor human----1件: 65 💬
96C1 esterase inhibitor liquid FOR injection----1件: 65 💬
97C1 inhibitor1件: Human C1-esterase inhibitor---1件: 65 💬
98C1 inhibitor concentrate1件: Human C1-esterase inhibitor---1件: 65 💬
99C1-esterase inhibitor----1件: 65 💬
100C1-esterase inhibitor - single intravenous dose----1件: 65 💬
101C1-esterase inhibitor - subcutaneous high dose----1件: 65 💬
102C1-esterase inhibitor - subcutaneous LOW dose----1件: 65 💬
103C1-esterase inhibitor - subcutaneous medium dose----1件: 65 💬
104C1-esterase-inhibitor----1件: 65 💬
105C1-INH1件: Human C1-esterase inhibitor---1件: 65 💬
106Campath -1H----1件: 65 💬
107Campath 1H----4件: 60, 65, 164, 285 💬
108Campath, fludarabine, cyclophosphamide----2件: 65, 284 💬
109Campath-1H1件: Alemtuzumab1件: Alemtuzumab 💬 --6件: 19, 20, 60, 65, 234, 326 💬
110Catapresan 75, tabletten----1件: 65 💬
111CD3/CD19 NEG allogeneic BMT----1件: 65 💬
112CD3/CD19 negative allogeneic hematopoietic stem cells----1件: 65 💬
113CD34 stem cell selection therapy----3件: 60, 65, 284 💬
114CD34+ cell enriched stem cell graft----2件: 65, 285 💬
115CD34+ hscs transduced with THE lentivirus vector, VSV-G pseudotyped CL20-4I-EF1A-H?C-OPT----1件: 65 💬
116CD34+cells----2件: 65, 285 💬
117CDZ173----2件: 53, 65 💬
118CE1145----1件: 65 💬
119Chemotherapy, intrathecal chemotherapy, steroid therapy----1件: 65 💬
120Cinryze----1件: 65 💬
121Cinryze 1000----1件: 65 💬
122Cinryze 1000 U----1件: 65 💬
123Cinryze 500----1件: 65 💬
124Cinryze 500 U----1件: 65 💬
125Cinryze with rhuph20----1件: 65 💬
126CL20-I4-EF1A-H?C-OPT----1件: 65 💬
127Clinimacs----2件: 60, 65 💬
128Clonidinhydrochlorid----1件: 65 💬
129Code ATC:L01xc04----1件: 65 💬
130Collection OF samples----4件: 49, 65, 95, 107 💬
131Complement C1 esterase inhibitor1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 61, 65 💬
132Computed tomography----12件: 26, 28, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
133Conestat alfa1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
134Continuous glucose monitor----2件: 65, 298 💬
135Covid-19 vaccine moderna----4件: 46, 51, 65, 272 💬
136Cryopreserved autologous CD34+ cells transduced with pcclchim-P47----1件: 65 💬
137Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65 💬
138Cryopreserved G2scid lentiviral vector transduced patient CD34+ cells----1件: 65 💬
139CSL312----2件: 65, 85 💬
140CSL312 garadacimab1件: Garadacimab1件: Garadacimab 💬 1件: F12 💬 1件: Complement and coagulation cascades 💬2件: 65, 85 💬
141CSL830----1件: 65 💬
142CT scan----2件: 65, 75 💬
143Cultured thymus tissue----1件: 65 💬
144Cultured thymus tissue implantation and parental parathyroid transplantation----1件: 65 💬
145Cultured thymus tissue implantation with parathyroid transplantation----1件: 65 💬
146Cutaquig----1件: 65 💬
147Cuvitru1件: Human immunoglobulin G1件: Globulin, immune 💬 --1件: 65 💬
148Cuvitru 200 MG/ML solution FOR subcutaneous injection1件: Human immunoglobulin G1件: Globulin, immune 💬 --1件: 65 💬
149Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
150Cyclophosphamide dose level 11件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
151Cyclophosphamide dose level 21件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
152Cyclophosphamide dose level 31件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
153Cyclophosphamide dose level 41件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
154Cyclophosphamide post transplant1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 65 💬
155Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬28件: 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
156Cyclosporine + BCX73532件: Berotralstat,
Cyclosporine		3件: Cyclosporine ,
Berotralstat ,
Berotralstat hydrochloride 💬 		6件: KLKB1,
PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Complement and coagulation cascades, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
157Cyclosporins----4件: 53, 60, 65, 222 💬
158Cyklokapron1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 65 💬
159Cyklokapron tablets1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 65 💬
160Daclizumab1件: Daclizumab1件: Daclizumab 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬8件: 13, 56, 60, 65, 97, 107, 283, 284 💬
161Danazol1件: Danazol1件: Danazol 💬 3件: AR,
ESR1,
PGR 💬 		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 60, 63, 64, 65, 285 💬
162Data collection----2件: 65, 299 💬
163Deucrictibant1件: Deucrictibant1件: Deucrictibant 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
164Deucrictibant high dose1件: Deucrictibant1件: Deucrictibant 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
165Deucrictibant LOW dose1件: Deucrictibant1件: Deucrictibant 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
166Deucrictibant selected dose1件: Deucrictibant1件: Deucrictibant 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
167Dexametasone fosfato sodico----1件: 65 💬
168Dexamethasone sodium phosphate1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 65, 70 💬
169Dexamethasone, procarbazine1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
170Dextrose, 5% IN water1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--1件: 65 💬
171Direct intravenous injection OF IVLV-X1 lentiviral vector----1件: 65 💬
172Donidalorsen1件: Donidalorsen---1件: 65 💬
173Donor mobilized pbsc infusion----3件: 60, 65, 285 💬
174Dose 1 OF BMN 331----1件: 65 💬
175Dose 2 OF BMN 331----1件: 65 💬
176Dose 3 OF BMN 331----1件: 65 💬
177Dose 4 OF BMN 331----1件: 65 💬
178Dose 5 OF BMN 331----1件: 65 💬
179Dose 6 OF BMN 331----1件: 65 💬
180Dose 7 OF BMN 331----1件: 65 💬
181Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase1件: Doxorubicin2件: Doxorubicin hydrochloride ,
Doxorubicin 💬 		--1件: 65 💬
182DX-2930----1件: 65 💬
183DX-2930 - 150MG/4WK----1件: 65 💬
184DX-2930 - 300MG/2WK----1件: 65 💬
185DX-2930 - 300MG/4WK----1件: 65 💬
186DX-88----1件: 65 💬
187DX2930----1件: 65 💬
188Ecallantide1件: Ecallantide1件: Ecallantide 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
189Ecallantide subcutaneous dosing1件: Ecallantide1件: Ecallantide 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
190Echocardiography----7件: 28, 58, 60, 62, 65, 284, 286 💬
191Efficacy OF gammagard subcutaneously AT week 12----1件: 65 💬
192Efficacy OF gammagard subcutaneously AT week 24----1件: 65 💬
193Efficacy OF gammagard subcutaneously AT week 36----1件: 65 💬
194Efficacy OF gammagard subdermally AT week 12----1件: 65 💬
195Efficacy OF gammagard subdermally AT week 24----1件: 65 💬
196Efficacy OF gammagard subdermally AT week 36----1件: 65 💬
197Elapegademase-lvlr1件: Elapegademase1件: Elapegademase 💬 1件: add 💬 2件: Primary immunodeficiency, Purine metabolism 💬1件: 65 💬
198Eltrombopag1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬5件: 60, 63, 65, 284, 285 💬
199Emapalumab-izsg1件: Emapalumab1件: Emapalumab 💬 1件: IFNG 💬 32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 65 💬
200Empagliflozin1件: Empagliflozin1件: Empagliflozin 💬 --10件: 65, 67, 72, 77, 86, 96, 97, 257, 298, 299 💬
201EN-374----1件: 65 💬
202EP2006----1件: 65 💬
203Erydex high dose DSP----1件: 65 💬
204Erydex LOW dose DSP----1件: 65 💬
205Estradiolvalerat----1件: 65 💬
206Etoposide1件: Etoposide2件: Etoposide ,
Etoposide phosphate 💬 		--12件: 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
207Etoposide, cytarabine, mercaptopurine1件: Etoposide2件: Etoposide ,
Etoposide phosphate 💬 		--1件: 65 💬
208EX vivo culture and transduction OF THE patient'S autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4I-EF1alpha-hgammac-OPT vector----1件: 65 💬
209EX-vivo GENE-therapy----1件: 65 💬
210EZN-2279----1件: 65 💬
211Facs analyses----1件: 65 💬
212Factor xiia antagonist monoclonal antibody----2件: 65, 85 💬
213Factor xiia inhibitor monoclonal antibody----1件: 65 💬
214Fibrinogen concentrate from human plasma1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 65 💬
215Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬29件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
216Filgrastim hexal1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
217Firazyr1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
218Firazyr (icatibant) 30 MG solution FOR injection IN PRE filled syringe1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
219Firazyr 30 MG solucióN inyectable EN jeringa precargada1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
220Firazyr 30 MG solution FOR injection IN PRE-filled syringe1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
221Firazyr*SC 1SIR 30MG 3ml10MG/M1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
222Firazyr® 30 MG subcutaneous injection syringe: 3.0 ML×1 syringe1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
223Fisetin1件: Fisetin---1件: 65 💬
224Flebogamma 5% DIF----1件: 65 💬
225Flow cytometry----6件: 28, 41, 51, 60, 65, 285 💬
226Fludarabina accord1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
227Fludarabina teva - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 1 flaconcino DI vetro DA 2 ML1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
228Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬23件: 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
229Fludarabine monophosphate1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 65, 284, 326 💬
230Fludarabine phosphate1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬12件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 💬
231Fludarabine phosphate 30 MG1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
232Fludarabine phosphate 40 MG1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
233Fludarabine, busulfan, thymoglobulin1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
234Fludarabine, melphalan, thiotepa1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
235Food diary----1件: 65 💬
236Functional and antigenic C1 inhibitor----1件: 65 💬
237Fxiia inhibitor monoclonal antibody----2件: 65, 85 💬
238G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬18件: 2, 6, 11, 13, 16, 22, 47, 49, 51, 60, 61, 62, 65, 85, 96, 284, 285, 331 💬
239G1XCG----1件: 65 💬
240G1xcgd transduced CD34+ cells----1件: 65 💬
241Gadolinium FOR abdomen1件: Gadolinium---1件: 65 💬
242Gadolinium FOR lower back1件: Gadolinium---1件: 65 💬
243Gammagard liquid----1件: 65 💬
244Gammaglobulin----1件: 65 💬
245Gammanorm----2件: 14, 65 💬
246Gammanorm 165 MG/ML----1件: 65 💬
247Gammaplex1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 63, 65 💬
248Gammaplex 101件: Human immunoglobulin G1件: Globulin, immune 💬 --1件: 65 💬
249Gamunex-C----1件: 65 💬
250Garadacimab1件: Garadacimab1件: Garadacimab 💬 1件: F12 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
251Gcsf----1件: 65 💬
252Gene therapy method FOR CGD----1件: 65 💬
253GENE-transduced autologous CD34+ stem cells----1件: 65 💬
254Genetically modified autologous blood stem cells----1件: 65 💬
255Glycosade----3件: 65, 256, 257 💬
256GNR-038, 100 ??/ KG----1件: 65 💬
257GNR-038, 100 ??/KG----1件: 65 💬
258GNR-038, 25 ??/KG----1件: 65 💬
259GNR-038, 50 ??/ KG----1件: 65 💬
260GNR-038, 50 ??/KG----1件: 65 💬
261GP91 grans----1件: 65 💬
262Granulocyte colony stimulating factor----6件: 2, 28, 36, 57, 65, 85 💬
263GTG003.08----1件: 65 💬
264GTX-102 high dose fast period 1 and period 21件: GTX-102---1件: 65 💬
265GTX-102 LOW dose fast period 1 and period 21件: GTX-102---1件: 65 💬
266GTX-102 medium dose fast period 1 and period 21件: GTX-102---1件: 65 💬
267GTX-102 medium dose slow period 1 and period 21件: GTX-102---1件: 65 💬
268Gvhd prophylaxis----2件: 60, 65 💬
269Haemocomplettan P----1件: 65 💬
270Haemocomplettan(R) P 1G/2G----1件: 65 💬
271Haploidentical hematopoietic cell transplantation----2件: 60, 65 💬
272Hematopoetic stem cell transplantation----6件: 19, 65, 121, 160, 308, 326 💬
273Hematopoietic stem cell transplant----2件: 65, 285 💬
274Hematopoietic stem cell transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
275Heparin1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬7件: 47, 60, 65, 70, 84, 107, 226 💬
276Higher-volume C1-esterase inhibitor----1件: 65 💬
277Hizentra1件: Human immunoglobulin G1件: Globulin, immune 💬 --4件: 14, 50, 51, 65 💬
278HU-G012267----1件: 65 💬
279Human fibrinogen1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 65 💬
280Human fibrinogen concentrate1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 65 💬
281Human immunoglobulin----2件: 63, 65 💬
282Human normal immunoglobulin1件: Human immunoglobulin G1件: Globulin, immune 💬 --8件: 11, 13, 14, 43, 45, 50, 63, 65 💬
283Human normal immunoglobulin FOR intravenous administration1件: Human immunoglobulin G1件: Globulin, immune 💬 --3件: 14, 51, 65 💬
284Human normal immunoglobulin FOR intravenous USE1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 63, 65 💬
285Human normal immunoglobulin FOR subcutaneous administration1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 51, 65 💬
286Hyaluronoglucosaminidase1件: Hyaluronidase2件: Hyaluronidase ,
Hyaluronidase 💬 		--1件: 65 💬
287Hydroxyurea1件: Hydroxyurea1件: Hydroxyurea 💬 1件: RRM2 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬10件: 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
288Hyqvia1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 14, 65 💬
289Hyqvia 100 MG/ML solution FOR infusion FOR subcutaneous USE1件: Human immunoglobulin G1件: Globulin, immune 💬 --1件: 65 💬
290I.V. recombinant human C1 inhibitor----1件: 65 💬
291I10E----3件: 14, 63, 65 💬
292IB 1001----1件: 65 💬
293IB1001----2件: 19, 65 💬
294Ibuprofen1件: Ibuprofen5件: Ibuprofen ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬6件: 13, 46, 65, 113, 271, 299 💬
295Icaspase9-transduced T cells----1件: 65 💬
296Icatibant1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
297Icatibant acetate1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
298Icatibant acetate solution FOR injection 10 MG/ML1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
299IFN-gamma----1件: 65 💬
300IG vena 50 G/L solution FOR infusion 100 ML vial + infusion SET----2件: 63, 65 💬
301IGG next generation----2件: 63, 65 💬
302IGHY10----1件: 65 💬
303Igng----1件: 65 💬
304Igpro10----4件: 14, 51, 63, 65 💬
305Igpro20----4件: 14, 50, 51, 65 💬
306Igsc 20% 150 MG/KG----1件: 65 💬
307Igsc 20% daily push versus 2 times PER week pump----1件: 65 💬
308Igsc 20% daily push versus every 2 weeks pump----1件: 65 💬
309Igsc 20% daily push versus once A week pump----1件: 65 💬
310Igsc 20% infusion----1件: 65 💬
311Immune globulin intravenous----2件: 63, 65 💬
312Immune globulin intravenous (human), 10% solution----1件: 65 💬
313Immune globulin intravenous (human), 10% TVR (triple virally reduced) solution----1件: 65 💬
314Immune globulin intravenous [human], 10% caprylate/chromatography purified----1件: 65 💬
315Immune globulin subcutaneous (human), 20% solution----1件: 65 💬
316Immune globulin subcutaneous (human), 20%, caprylate/chromatography purified----1件: 65 💬
317Immunoglobulin G----9件: 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
318Immunoglobulina umana normale----3件: 51, 63, 65 💬
319Immunoglobulins, normal human----1件: 65 💬
320Immunologic technique----3件: 49, 65, 285 💬
321Immunological diagnosis tests----1件: 65 💬
322Immunosuppression only conditioning----1件: 65 💬
323Immunosuppression only conditioning -closed with amendment L----1件: 65 💬
324IN vitro-treated peripheral blood stem cell transplantation----2件: 60, 65 💬
325Increlex1件: Mecasermin2件: Mecasermin ,
Mecasermin rinfabate 💬 		2件: GHR,
IGF1R 💬 		32件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬2件: 65, 96 💬
326Infliximab1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 164, 269, 270, 271 💬
327Infusion OF autologous EFS-ADA LV CD34+ cells----1件: 65 💬
328Infusion OF lentiviral TYF-CGD-modified autologous stem cells----1件: 65 💬
329INH----1件: 65 💬
330Inhibidor DE LA esterasa C1 complemento----1件: 65 💬
331Interferon gamma1件: Interferon Gamma---3件: 65, 96, 326 💬
332Interferon gamma-1B2件: Interferon Gamma,
Interferon gamma-1b		1件: Interferon gamma-1b 💬 2件: IFNGR1,
IFNGR2 💬 		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326 💬
333Interferon-gamma----1件: 65 💬
334Interleukin-21件: Human interleukin-2---9件: 2, 13, 49, 50, 55, 65, 96, 97, 162 💬
335Intratect----4件: 13, 14, 35, 65 💬
336Intravenous immunoglobulin infusion----1件: 65 💬
337Intravenous infusion OF transduced cells----1件: 65 💬
338Isis 721744----1件: 65 💬
339Isolex 300I magnetic cell selector----1件: 65 💬
340Itraconazole1件: Itraconazole1件: Itraconazole 💬 --7件: 2, 3, 65, 96, 97, 227, 299 💬
341Ivig----8件: 11, 13, 14, 35, 51, 63, 65, 172 💬
342IVIG-PEG----1件: 65 💬
343Jardiance1件: Empagliflozin1件: Empagliflozin 💬 --2件: 65, 86 💬
344JE049----1件: 65 💬
345JSP191----2件: 65, 285 💬
346KIG10----1件: 65 💬
347Kineret1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬6件: 41, 49, 65, 106, 266, 299 💬
348Kiovig1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 14, 65 💬
349Kiovig 100 MG/ML solution FOR infusion1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 14, 65 💬
350KLH----2件: 13, 65 💬
351KVD824----1件: 65 💬
352KVD824 300 MG compresse A rilascio modificato----1件: 65 💬
353KVD824 300 MG modified release tablets----1件: 65 💬
354KVD824 hydrochloride----1件: 65 💬
355KVD824 immediate-release capsule----1件: 65 💬
356KVD824 prototype 1 modified-release tablet----1件: 65 💬
357KVD824 prototype 2 modified-release tablet----1件: 65 💬
358KVD824 prototype 3 modified-release tablet----1件: 65 💬
359KVD900----1件: 65 💬
360KVD900 100 MG film coated tablet----1件: 65 💬
361KVD900 150 MG----1件: 65 💬
362KVD900 300 MG----1件: 65 💬
363KVD900 300 MG compressa rivestita CON film----1件: 65 💬
364KVD900 300 MG film coated tablet----1件: 65 💬
365KVD900 600 MG----1件: 65 💬
366KVD900 75 MG----1件: 65 💬
367L-arginin-hydrochlorid-einmolar fresenius1件: Arginine3件: Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride 💬 		--1件: 65 💬
368L-fucose----1件: 65 💬
369Laboratory biomarker analysis----22件: 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
370Ladicell----1件: 65 💬
371Lanadelumab1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
372Lanadelumab 150 MG1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
373Lanadelumab 300 MG1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
374Lapine T-lymphocyte immune globulin1件: Antithymocyte immunoglobulin (rabbit)1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬4件: 62, 65, 284, 286 💬
375Lemtrada1件: Alemtuzumab1件: Alemtuzumab 💬 --2件: 13, 65 💬
376Leniolisib1件: Leniolisib2件: Leniolisib ,
Leniolisib phosphate 💬 		3件: PIK3CA_B_D,
PIK3CA_B_D,
PIK3CA_B_D 💬 		103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬2件: 53, 65 💬
377Leniolisib phosphate1件: Leniolisib2件: Leniolisib ,
Leniolisib phosphate 💬 		3件: PIK3CA_B_D,
PIK3CA_B_D,
PIK3CA_B_D 💬 		103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 65 💬
378Lenograstim1件: Lenograstim1件: Lenograstim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬8件: 2, 13, 16, 18, 19, 57, 65, 97 💬
379Lentiviral G1xcgd gene therapy----1件: 65 💬
380Lentiviral gene transfer----1件: 65 💬
381Lentiviral vector transduced CD34+ cells----1件: 65 💬
382LFB-igsc----1件: 65 💬
383LOW-volume C1-esterase inhibitor----1件: 65 💬
384Mabcampath1件: Alemtuzumab1件: Alemtuzumab 💬 --3件: 13, 60, 65 💬
385Mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬17件: 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 61, 63, 64, 65, 83, 162, 222 💬
386Mabthera - 2 fiale 100 MG 10 ML1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 19, 65 💬
387Magnetic resonance imaging----11件: 13, 19, 22, 28, 34, 46, 65, 205, 285, 299, 344 💬
388MAS8251件: MAS825---1件: 65 💬
389Mavorixafor1件: Mavorixafor1件: Mavorixafor 💬 1件: CXCR4 💬 14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
390MBM-01----1件: 65 💬
391Mctls----1件: 65 💬
392Medical history questionnaires----1件: 65 💬
393Melphalan1件: Melphalan2件: Melphalan ,
Melphalan hydrochloride 💬 		--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
394Mesna----11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
395Messenger RNA encoding CAS9----1件: 65 💬
396Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬23件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
397Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬37件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
398Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
399Methylprednisolone or prednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
400Miltenyi clinimacs selection system----1件: 65 💬
401MMF----15件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 84, 107, 222, 224, 226 💬
402Modified mixed meal tolerance test----1件: 65 💬
403Modified oral glucose tolerance test----1件: 65 💬
404Mozobil1件: Plerixafor1件: Plerixafor 💬 1件: CXCR4 💬 14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬2件: 65, 285 💬
405MTP 101-LF----1件: 65 💬
406Multigated acquisition scan----5件: 60, 62, 65, 284, 286 💬
407MUNC-CD34----1件: 65 💬
408MUNC-T3----1件: 65 💬
409Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬32件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
410Myeloablative conditioning-closed with amendment L----1件: 65 💬
411Myeloablative preparative regimen----3件: 62, 65, 284 💬
412Myelostim----1件: 65 💬
413Myelostim - 34 1 flaconcino liofilizzato 33.6 MIU + siringa preriempita solvente 1 ML----2件: 19, 65 💬
414Myelostim 34 milions UI/ML - powder and solvent FOR solution FOR injection/infusion----1件: 65 💬
415Myelostim 34 milions UI/ML, powder and solvent FOR solution FOR injection or infusion----1件: 65 💬
416N-acetyl-L-leucine1件: L-Acetylleucine---2件: 19, 65 💬
417Nanogam 100 MG/ML----1件: 65 💬
418Nanogam® 50 MG/ML----1件: 65 💬
419Navenibart----1件: 65 💬
420NDV-3A----1件: 65 💬
421Newgam----3件: 14, 63, 65 💬
422Newnorm----1件: 65 💬
423Nicotinamide riboside3件: Nicotinamide,
Nicotinamide riboside,
Zinc		1件: Niacinamide 💬 --13件: 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 191 💬
424Nonmyeloablative allogeneic hematopoietic stem cell transplantation----6件: 28, 51, 60, 62, 65, 285 💬
425Normal human immunoglobulin G----1件: 65 💬
426Normal saline IV administration----1件: 65 💬
427Norovirus -specific T-cell (NST) therapy----1件: 65 💬
428Noxafil 40 MG/ML oral solution1件: Posaconazole1件: Posaconazole 💬 --1件: 65 💬
429NTLA-20021件: NTLA-2002---1件: 65 💬
430Nutropinaq 10MG/2ML (30 I.E.) injektionsllösung1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 65 💬
431OCTA-C1-INH----1件: 65 💬
432Octagam1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 13, 65 💬
433Octanorm----2件: 50, 65 💬
434Omalizumab1件: Omalizumab1件: Omalizumab 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299 💬
435Orencia1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬15件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271, 300 💬
436Orencia® 125 MG solution FOR injection IN PRE-filled syringe1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 65 💬
437Orladeyo1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
438Other hematological agents----1件: 65 💬
439OTL-101----1件: 65 💬
440OTL-1031件: OTL-103---1件: 65 💬
441OTL-103 dispersion FOR infusion1件: OTL-103---1件: 65 💬
442Ovastat 10001件: Treosulfan1件: Treosulfan 💬 --2件: 13, 65 💬
443Ovastat 1000 MG, powder FOR solution FOR infusion1件: Treosulfan1件: Treosulfan 💬 --1件: 65 💬
444Ovastat 50001件: Treosulfan1件: Treosulfan 💬 --2件: 13, 65 💬
445Ovastat 5000 MG, powder FOR solution FOR infusion1件: Treosulfan1件: Treosulfan 💬 --1件: 65 💬
446Palifermin1件: Palifermin1件: Palifermin 💬 1件: FGFR2 💬 12件: Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬6件: 13, 36, 38, 39, 65, 96 💬
447Palliative care----6件: 19, 65, 121, 160, 308, 326 💬
448Pantoprazole1件: Pantoprazole2件: Pantoprazole sodium ,
Pantoprazole 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 13, 65 💬
449Pantoprazolo 20 MG gastro-resistant tablets----1件: 65 💬
450Pcclchimgp91S lentiviral vector transduced CD34+ cells infusion----1件: 65 💬
451PEG-ADA----1件: 65 💬
452PEG-interleukin-21件: PEG-interleukin-2---1件: 65 💬
453Peripheral blood stem cell transplantation----12件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
454Peripheral blood stem cells----4件: 51, 60, 62, 65 💬
455PHA-022121----1件: 65 💬
456PHA-022121 monohydrate----1件: 65 💬
457Phagocyte oxidase subunit transduced CD34 hematopoietic stem cells----1件: 65 💬
458Pheripheral blood stem cells----1件: 65 💬
459Phosphate1件: Phosphate ion---13件: 3, 11, 13, 46, 65, 70, 75, 90, 235, 238, 256, 286, 288 💬
460Phosphate buffer saline (PBS), PH 7.01件: Phosphate ion---1件: 65 💬
461PHVS416----1件: 65 💬
462PID----1件: 65 💬
463Pioglitazone1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬16件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
464Plerixafor1件: Plerixafor1件: Plerixafor 💬 1件: CXCR4 💬 14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬4件: 20, 51, 65, 285 💬
465PM359----1件: 65 💬
466Pncj PPS----1件: 65 💬
467Pneumo 23----2件: 65, 97 💬
468Polyclonal IGG----1件: 65 💬
469Polymerase chain reaction----4件: 28, 60, 65, 285 💬
470Posaconazole1件: Posaconazole1件: Posaconazole 💬 --3件: 60, 65, 299 💬
471Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
472Prevenar----1件: 65 💬
473Privigen1件: Human immunoglobulin G1件: Globulin, immune 💬 --5件: 11, 14, 51, 63, 65 💬
474Progynova 21 mite----1件: 65 💬
475Proleukin® S1件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 65 💬
476Promacta----1件: 65 💬
477PSRS11.EFS.IL2RG.PRE* retroviral vector----1件: 65 💬
478PTH 1-341件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬2件: 65, 235 💬
479Pyrimethamine1件: Pyrimethamine1件: Pyrimethamine 💬 --4件: 2, 4, 19, 65 💬
480Quality-OF-life assessment----11件: 28, 34, 36, 51, 62, 63, 65, 96, 284, 286, 298 💬
481R-HIL-18BP----1件: 65 💬
482Rabbit ANTI-thymocyte globulin1件: Rabbit---4件: 49, 65, 285, 326 💬
483Radiation therapy----6件: 13, 34, 60, 65, 284, 285 💬
484Ranitidine1件: Ranitidine3件: Ranitidine ,
Ranitidine hydrochloride ,
Ranitidine bismuth citrate 💬 		1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 13, 65 💬
485Recombinant human C1 esterase inhibitor----1件: 65 💬
486Recombinant human C1 inhibitor1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
487Recombinant human hyaluronidase2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--3件: 14, 28, 65 💬
488Recombinant human hyaluronidase + immune globulin intravenous1件: Hyaluronidase (human recombinant)1件: Hyaluronidase 💬 --1件: 65 💬
489Reduced intensity conditioning----2件: 19, 65 💬
490Reduced intensity preparative regimen----3件: 62, 65, 284 💬
491Reduced toxicity ablative regimen----3件: 62, 65, 284 💬
492Retroviral SF71-GP91phox transduced CD34+ cells----1件: 65 💬
493Retrovirus-mediated gene transfer----1件: 65 💬
494RHC1IHN----1件: 65 💬
495RHC1INH----1件: 65 💬
496RHC1INH or PDC1INH----1件: 65 💬
497Rhucd40L----1件: 65 💬
498RI-002----1件: 65 💬
499Rifaximin1件: Rifaximin1件: Rifaximin 💬 --8件: 6, 65, 93, 96, 97, 99, 296, 299 💬
500Rimiducid1件: Rimiducid1件: Rimiducid 💬 1件: CASP9 💬 34件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬7件: 19, 49, 60, 65, 284, 285, 326 💬
501Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
502Rivogenlecleucel1件: Rivogenlecleucel1件: Rivogenlecleucel 💬 --6件: 19, 60, 65, 284, 285, 326 💬
503Romiplostim1件: Romiplostim1件: Romiplostim 💬 1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65 💬
504Rosuvastatin + BCX73532件: Berotralstat,
Rosuvastatin		4件: Rosuvastatin calcium ,
Rosuvastatin ,
Berotralstat ,
Berotralstat hydrochloride 💬 		2件: HMGCR,
KLKB1 💬 		4件: AMPK signaling pathway, Bile secretion, Complement and coagulation cascades, Terpenoid backbone biosynthesis 💬1件: 65 💬
505RP-L2011件: RP-L201---1件: 65 💬
506RTX----3件: 13, 65, 222 💬
507Ruconest1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
508Ruconest - 2100 U - polvere PER soluzione iniettabile - USO endovenoso - flaconcino(vetro) 1 flaconcino DA 2100 U1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
509Ruconest 2100 U powder FOR solution FOR injection1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
510Ruxolitinib1件: Ruxolitinib2件: Ruxolitinib ,
Ruxolitinib phosphate 💬 		2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬5件: 13, 15, 60, 65, 228 💬
511SC investigational needle sets----2件: 14, 65 💬
512Sebetralstat1件: Sebetralstat1件: Sebetralstat 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
513SHP616----1件: 65 💬
514SHP623----1件: 65 💬
515SHP643----1件: 65 💬
516Single infusion OF autologous CD34+ cells transduced with THE SELF-inactivating (SIN) gammaretroviral vector PSRS11.EFS.IL2RG.PRE----1件: 65 💬
517Sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬39件: 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
518Somatic GENE-therapy BY X-CGD----1件: 65 💬
519Somatotropin1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 3, 65 💬
520Somatropin, clonidine, L-arginin-hydrochloride, estradiol valerate1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 65 💬
521Soquelitinib1件: Soquelitinib1件: Soquelitinib 💬 1件: ITK 💬 3件: Chemokine signaling pathway, Leukocyte transendothelial migration, T cell receptor signaling pathway 💬1件: 65 💬
522STA-5326----2件: 65, 96 💬
523STAR-0215----1件: 65 💬
524Stem cell infusion----4件: 28, 60, 65, 284 💬
525Stem cell transplant----7件: 19, 20, 60, 65, 96, 164, 284 💬
526Stem cell transplantation----13件: 13, 19, 20, 46, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
527Strimvelis1件: Strimvelis---1件: 65 💬
528Subcuvia----3件: 14, 49, 65 💬
529Subgam----1件: 65 💬
530Sulfadoxine1件: Sulfadoxine1件: Sulfadoxine 💬 --1件: 65 💬
531Suspension OF autologous CD34+cells transduced with THE G1xcgd viral vector----1件: 65 💬
532T-cell depleted & CD34+select/W/stemcell enriched product----1件: 65 💬
533Tabelecleucel1件: Tabelecleucel1件: Tabelecleucel 💬 --1件: 65 💬
534Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬31件: 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
535Tadekinig alfa1件: Tadekinig alfa---2件: 54, 65 💬
536TAK-667----1件: 65 💬
537TAK-743, SHP643, DX-2930----1件: 65 💬
538TAK-771----2件: 14, 65 💬
539TAK-881----2件: 14, 65 💬
540TAK743----1件: 65 💬
541Takhzyro1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
542TBI----3件: 60, 65, 285 💬
543TCR alfa beta T cell depletion----1件: 65 💬
544Temozolomide1件: Temozolomide1件: Temozolomide 💬 --2件: 34, 65 💬
545Thalidomide1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬20件: 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300 💬
546Therapeutic allogeneic lymphocytes1件: Therapeutic allogeneic lymphocytes---3件: 60, 65, 285 💬
547There IS NO recommended INN----1件: 65 💬
548Thiotepa1件: Thiotepa1件: Thiotepa 💬 --11件: 13, 28, 46, 51, 60, 65, 85, 96, 107, 284, 285 💬
549Thiotepa--escalated dose1件: Thiotepa1件: Thiotepa 💬 --4件: 19, 20, 65, 284 💬
550Thiotepa--single daily dose1件: Thiotepa1件: Thiotepa 💬 --4件: 19, 20, 65, 284 💬
551Thymafalsin----1件: 65 💬
552Thymalfasin1件: Thymalfasin1件: Thymalfasin 💬 --1件: 65 💬
553Thymus tissue FOR transplantation----1件: 65 💬
554Thymus/parathyroid transplantation----2件: 65, 235 💬
555TO BE confirmed----3件: 46, 65, 97 💬
556Tociluzumab----1件: 65 💬
557Tofacitinib1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬19件: 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 96, 97, 107, 110, 162, 271, 300 💬
558Total body 200CGY----1件: 65 💬
559Total body irradiation----13件: 19, 20, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284, 285 💬
560Total lymphoid irradiation----3件: 65, 284, 326 💬
561Total-body irradiation----9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
562Traditional treatment OF CGD and TB----1件: 65 💬
563Tranexamic acid1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬8件: 46, 65, 70, 215, 227, 274, 288, 299 💬
564Transplant preparative regimen OF alemtuzumab, fludarabine, thiotepa, and melphalan----2件: 65, 164 💬
565Treosulfan1件: Treosulfan1件: Treosulfan 💬 --6件: 13, 19, 62, 65, 284, 286 💬
566Triheptanoin1件: Triheptanoin1件: Triheptanoin 💬 --10件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬
567Tuvusertib1件: Tuvusertib1件: Tuvusertib 💬 1件: ATR 💬 7件: Cell cycle, Cellular senescence, Fanconi anemia pathway, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, p53 signaling pathway 💬1件: 65 💬
568Umbilical cord blood transplantation----5件: 60, 65, 284, 285, 326 💬
569Ustekinumab1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
570Valproic acid1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
571Verorab® (pvrv----1件: 65 💬
572Vigantol----2件: 13, 65 💬
573Vinblastine, vincristine, prednisone, daunorubicin1件: Vinblastine2件: Vinblastine sulfate ,
Vinblastine 💬 		9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 65 💬
574Vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬11件: 6, 13, 20, 46, 49, 51, 53, 65, 96, 97, 299 💬
575Vivaglobin----2件: 14, 65 💬
576VM106----1件: 65 💬
577VP 20624----1件: 65 💬
578Whole exome sequencing----6件: 2, 6, 65, 120, 127, 149 💬
579X vivo gene therapy----1件: 65 💬
580X-RAY imaging----5件: 28, 62, 65, 284, 286 💬
581X4P-001----1件: 65 💬
582Xifaxan----2件: 65, 94 💬
583Zadaxin----2件: 65, 299 💬
584Zarzio1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬3件: 38, 65, 285 💬
585Zoledronate1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬2件: 46, 65 💬